Cite
HARVARD Citation
Haldar, D. et al. (2021). Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis. Liver international. pp. 535-544. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Haldar, D. et al. (2021). Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis. Liver international. pp. 535-544. [Online].